These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25859676)

  • 1. Communicating vaccine safety during the development and introduction of vaccines.
    Kochhar S
    Curr Drug Saf; 2015; 10(1):55-9. PubMed ID: 25859676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communicating vaccine safety in the context of immunization programs in low resource settings.
    Arwanire EM; Mbabazi W; Mugyenyi P
    Curr Drug Saf; 2015; 10(1):68-75. PubMed ID: 25859678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine safety monitoring systems in developing countries: an example of the Vietnam model.
    Ali M; Rath B; Thiem VD
    Curr Drug Saf; 2015; 10(1):60-7. PubMed ID: 25859677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communicating vaccine safety to the media and general public.
    Oubari H; Tuttle R; Rath B; Bravo L
    Curr Drug Saf; 2015; 10(1):80-6. PubMed ID: 25859680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need to teach vaccine safety to basic scientists and public health officials.
    Khamesipour A
    Curr Drug Saf; 2015; 10(1):76-9. PubMed ID: 25859679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk communication of vaccines: challenges in the post-trust environment.
    Bouder F
    Curr Drug Saf; 2015; 10(1):9-15. PubMed ID: 25859669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Communicating vaccine safety - the Vienna Vaccine Safety Initiative.
    Rath B
    Curr Drug Saf; 2015; 10(1):3-4. PubMed ID: 25859667
    [No Abstract]   [Full Text] [Related]  

  • 8. A design thinking approach to effective vaccine safety communication.
    Seeber L; Michl B; Rundblad G; Trusko B; Schnjakin M; Meinel C; Weinberg U; Gaedicke G; Rath B
    Curr Drug Saf; 2015; 10(1):31-40. PubMed ID: 25859673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the parent-physician relationship on parental vaccine safety perceptions.
    Kundi M; Obermeier P; Helfert S; Oubari H; Fitzinger S; Yun JA; Brix M; Rath B
    Curr Drug Saf; 2015; 10(1):16-22. PubMed ID: 25859670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why some messages speak better: child immunization in the news and on the internet.
    Rundblad G
    Curr Drug Saf; 2015; 10(1):87-93. PubMed ID: 25859681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical aspects of immunization and vaccine safety communication.
    Helfert SM
    Curr Drug Saf; 2015; 10(1):5-8. PubMed ID: 25859668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of precise documentation of vaccination by physicians and vaccine providers.
    Maurer W
    Curr Drug Saf; 2015; 10(1):27-30. PubMed ID: 25859672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive medicines: vaccination, prophylaxis of infectious diseases, disinfectants.
    Heininger U
    Handb Exp Pharmacol; 2011; 205():317-37. PubMed ID: 21882119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.
    Kanesa-thasan N; Shaw A; Stoddard JJ; Vernon TM
    Pediatrics; 2011 May; 127 Suppl 1():S16-22. PubMed ID: 21502248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany : criteria for the assessment of benefits and risks].
    Pfleiderer M; Wichmann O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Mar; 58(3):263-73. PubMed ID: 25566841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and assessing vaccine safety: a European perspective.
    Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
    Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIOMS Guide To Vaccine Safety Communication - Executive summary.
    Bahri P; Rägo L;
    Vaccine; 2019 Jan; 37(3):401-408. PubMed ID: 30554796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of Vaccine Safety in Children with Chronic Conditions--Experience at the Scientific Centre for Children's Health in Moscow, Russia.
    Grechukha TA; Galitskaya MG; Namazova-Baranova LS
    Curr Drug Saf; 2015; 10(1):49-54. PubMed ID: 25859675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Listen to the public and fulfil their information interests - translating vaccine communication research findings into guidance for regulators.
    Bahri P; Castillon Melero M
    Br J Clin Pharmacol; 2018 Aug; 84(8):1696-1705. PubMed ID: 29573274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.